Search

Search Results

• PO116 | MONOCENTRIC EXPERIENCE OF DOACS REVERSAL MANAGEMENT AT L SACCO HOSPITAL, MILAN: A REAL-WORLD RETROSPECTIVE STUDY A. Veltroni, C. Sitzia, O. Di Bartolo, IM Burgo, MC. Carraro, S. Crivelli, C. Masseroni, GB. Inghilleri | Medicina Trasfusionale, Ospedale L. Sacco, Milano, Italy

  Alessio Veltroni

  26-10-2026

  https://doi.org/10.4081/btvb.2026.932

  0

  PDF: 0

• CO114 | ANTI-PS/PT IgM IDENTIFIES AN ANTIGEN-DEFINED SUBSET WITHIN LUPUS ANTICOAGULANT POSITIVITY ASSOCIATED WITH THROMBOTIC PHENOTYPE M. Sacco¹, S. Lancellotti¹, A. Ferretti¹, M. Basso¹, C. Gavotti², A. Ortolan², V.A. Pacucci², P. Calzoni³, L. Puccetti³, R. De Cristofaro^1|4 | ¹Center for Hemorrhagic and Thrombotic Diseases; ²Rheumatology and Clinical Immunology Unit, Fondazione Policl. Univ. Gemelli IRCCS, Roma, Italy; ³Azienda Ospedaliera-Universitaria Senese, Unità specialistica Coagulopatie Trombotiche ed Emorragiche, Dipartimento di Scienze Mediche, Chirurgiche e Neuroscienze, Università di Siena, Siena, Italy; ⁴Department of Translational Medicine and Surgery, Catholic University of the Sacred Heart, Roma, Italy

  Raimondo De Cristofaro

  26-10-2026

  https://doi.org/10.4081/btvb.2026.816

  1

  PDF: 0

• CO108 | MECHANOCHEMICAL REPROGRAMMING OF VWF–GPIB INTERACTIONS UNCOUPLES AFFINITY FROM AVIDITY AND LINKS THROMBOCYTOPENIA TO ANGIODYSPLASIA IN TYPE 2B VON WILLEBRAND DISEASE A. Ferretti¹, M. Sacco¹, S. Lancellotti¹, P. Concolino², A. Minucci², R. De Cristofaro^1|3 | ¹Center for Hemorrhagic and Thrombotic Diseases; ²Molecular and Genomic Diagnostics Unit, Fondazione Policl.nico Univ. Gemelli IRCCS, Roma, Italy; ³Department of Translational Medicine and Surgery, Catholic University of the Sacred Heart, Roma, Italy

  Raimondo De Cristofaro

  26-10-2026

  https://doi.org/10.4081/btvb.2026.810

  0

  PDF: 0

• PO129 | CLINICAL BENEFIT OF RECOMBINANT ADAMTS13 IN CTTP ASSOCIATED WITH HOMOZYGOUS PD173G MUTATION AND UNDETECTABLE ACTIVITY M. Sacco¹, S. Lancellotti¹, M. Basso¹, R. De Cristofaro^1|2 | ¹Servizio Malattie Emorragiche e Trombotiche, Fondazione Policlinico Universitario Gemelli IRCCS, Roma, Italy; ²Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica S. Cuore, Roma, Italy

  Raimondo De Cristofaro

  26-10-2026

  https://doi.org/10.4081/btvb.2026.945

  0

  PDF: 0

• CO006 | PREVALENCE OF GASTROINTESTINAL BLEEDING IN GLANZMANN THROMBASTHENIA PATIENTS: RESULTS OF A WORLDWIDE SURVEY E. Falcinelli¹, L. Bury¹, S. Morais², M. de Oliveira², M. Kannan³, M. Faranoush⁴, D. Desprez⁵, V. Jean-Baptiste⁶, C. Santoro⁷, C. Falaise⁸, P. Saultier⁸, M. Fiore⁹, C. Albayrak¹⁰, A. Sánchez¹¹, J.M. Bastida¹², A. Artoni¹³, G. Castaman¹⁴, K. Gomez¹⁵, R. Schutgens¹⁶, L. Spiezia¹⁷, M. Sridharan¹⁸, N. Butta¹⁹, P. Buur van Kooten Niekerk²⁰, E. Leinøe²¹, B. Guillet²², C. Panagiotis²³, S. Crivelli²⁴, E. De Candia²⁵, M. Lewandowska²⁶, P. De Bonis²⁷, G. Kenet²⁸, F. Heubel-Moenen²⁹, J. Payne³⁰, L. Banov³¹, L. Puccetti³², M. Olivieri³³, M. Chitlur³⁴, M. Lambert³⁵, A. Pecci³⁶, D. Martínez-Carballeira³⁷, E. Zetterberg³⁸, J. Curnow³⁹, M. Napolitano⁴⁰, A. Morotti⁴¹, R.C. Santoro⁴², R. Johann⁴³, S. Saulyte Trakymiene⁴⁴, A. Falanga⁴⁵, C. Casas⁴⁶, E. Zanon⁴⁷, J. Moppet⁴⁸, N.M. Popa-Fotea⁴⁹, P. Gresele¹ | ¹Department of Medicine and Surgery, Section of Internal and Cardiovascular Medicine, University of Perugia, Italy; ²Centro Hospitalar Universitário de Santo António, Portugal; ³Blood and Vascular Biology Research Lab, Department of Biotechnology, Central University of Tamil Nadu, India; ⁴Iranian Hemophilia and Thrombophilia Association, MAHTA, Iran; ⁵CRC MHC Hopital Universaitire de Strasbourg, France; ⁶CHRU de Tours, University Hospital of Tours, France; ⁷UOC Ematologia, Azienda Ospedaliero Universitaria Policlinico Umberto I, Roma, Italy; ⁸AP-HM Timone, Marseille, France; ⁹CHU Bordeaux, France; ¹⁰Mayıs University Medical Faculty Pediatric Hematology and Oncology Dept, Türkiye; ¹¹Hospital Universitario Morales Meseguer – Centro Regional de Hemodonación, Murcia, Spain; ¹²Complejo Asistencial Universitario De Salamanca, Spain; ¹³Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano, Italy; ¹⁴Azienda Ospedaliera Universitaria Careggi Florence, Italy; ¹⁵Royal Free Hospital, London, UK; ¹⁶Center for Benign Haematology, Thrombosis and Haemostasis, Van Creveldkliniek, UMC Utrecht, The Netherlands; ¹⁷University of Padova, Italy; ¹⁸Mayo Clinic, Rochester, USA; ¹⁹Hospital Universitario La Paz-IdiPAZ, Madrid, Spain; ²⁰Aarhus University Hospital, Denmark; ²¹Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; ²²University Hospital of Rennes, France; ²³Blood unit and National Reference Center for Congenital Bleeding Disorders, ''Laiko'' General Hospital, Greece; ²⁴Ospedale L. Sacco e Polo Universitario, Milano, Italy; ²⁵Università Cattolica del Sacro Cuore-Roma, Fondazione Policlinico Universitario A. Gemelli IRCCS, Italy; ²⁶Indiana Hemophilia and Thrombosis Center Innovative Hematology, USA; ²⁷IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy; ²⁸Sheba Medical Center, Israel; ²⁹Department of Hematology Internal Medicine, Maastricht University Medical Center and Hemophilia Treatment Center Nijmegen Eindhoven Maastricht and CARIM, Maastricht University, Maastricht, Netherlands; ³⁰Sheffield Children’s NHS foundation Trust, UK; ³¹Hemostasis and Thrombosis Unit, Gaslini Children’s Hospital, Italy; ³²University Teaching Hospital of Siena, Italy; ³³Pediatric Thrombosis and Hemostasis Unit, Dr. von Hauner Childreńs Hospital, LMU Munich, Munich, Germany; ³⁴Children's Hospital of Michigan, USA; ³⁵Children’s Hospital of Philadelphia, USA; ³⁶IRCCS Policlinico San Matteo Foundation and University of Pavia, Italy; ³⁷Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Spain; ³⁸Department of Hematology, Coagulation Unit, Skane University hospital, Sweden; ³⁹Westmead Hospital, Sydney, Australia; ⁴⁰PROMISE Department, University of Palermo, Italy; ⁴¹AOU San Luigi Gonzaga Hospital, University of Turin, Italy; ⁴²Hemostasis and Thrombosis, Az. Osp. Univ. Dulbecco, Catanzaro, Italy; ⁴³Hospital Center of Le Mans, France; ⁴⁴Vilnius University Hospital Santaros Klinikos, Lithuania; ⁴⁵ASST Papa Giovanni XXIII, Bergamo, Italy; ⁴⁶Hospital San José, Bogotà, Colombia; ⁴⁷Haemophilia Center-General Medicine, Padova University Hospital, Padova, Italy; ⁴⁸University Hospitals Bristol NHS Foundation Trust, UK; ⁴⁹University of Medicine and Pharmacy “Carol Davila”, Bucharest, Romania

  Loredana Bury

  26-10-2026

  https://doi.org/10.4081/btvb.2026.708

  0

  PDF: 0

• PO105 | IMPACT OF ECOG PERFORMANCE STATUS ON CANCER-ASSOCIATED THROMBOSIS TREATED WITH DOACS: DATA FROM A MULTICENTER COHORT STUDY R. Talerico¹, F. Mancinetti¹, C. Sacco², M. Mazzetti³, E. Campello⁴, S. Birocchi⁵, S. Beccatini⁶, A. Porfidia¹, C. Lodigiani², P. Simioni⁴, G.M. Podda⁵, I. Mastandrea², C. Becattini⁶, R. Pola¹, M.C. Vedovati⁶ | ¹Thrombosis Unit, Department of Geriatric, Orthopedic, and Rheumatologic Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy; ²Thrombosis and Hemorrhagic Diseases Unit, IRCCS Humanitas Research Hospital, Rozzano, Milano, Italy; ³Interdisciplinary Internal Medicine, Careggi University Hospital, Firenze, Italy; ⁴First Chair of Internal Medicine and Thrombotic and Hemorrhagic Diseases Unit, Department of Medicine, University of Padova, Italy; ⁵Medicine II Unit, ASST Santi Paolo e Carlo, Department of Health Sciences, University of Milano, Milano, Italy; ⁶Internal, Vascular and Emergency Medicine– Stroke Unit, University of Perugia, Perugia, Italy

  Rosa Talerico

  26-10-2026

  https://doi.org/10.4081/btvb.2026.921

  0

  PDF: 0

• PO063 | EVALUATION OF PLATELET ACTIVATION MARKERS IN PATIENTS WITH THROMBOTIC THROMBOCYTOPENIC PURPURA M. Di Fuorti¹, M.R. Cozzi², A. Steffan³, I. Quaglia¹, C. Sacco¹, C. Lodigiani¹, M. Bacci¹ | ¹Center for Thrombosis and Hemorrhagic Diseases, IRCCS Humanitas Research Hospital, Rozzano, Italy; ²Immunopathology and Cancer Biomarkers Unit, Centro di Riferimento Oncologico di Aviano IRCCS, Aviano, Italy; ³Clinical Pathology Unit, ASFO General Hospital, Pordenone, Italy

  Marialaura Di Fuorti

  26-10-2026

  https://doi.org/10.4081/btvb.2026.879

  0

  PDF: 0

• PO045 | FROM PROPHYLAXIS TO ENDOGENOUS CONTROL: A SIX-MONTH REAL-WORLD EXPERIENCE WITH VALOCTOCOGENE ROXAPARVOVEC GENE THERAPY M. Basso¹, A. Ferretti¹, M. Sacco¹, S. Lancellotti¹, T. Pirozzi¹, L. Di Gennaro¹, R. De Cristofaro^1|2 | ¹Servizio Malattie Emorragiche e Trombotiche, Fondazione Policlinico Universitario Gemelli IRCCS, Italy; ²Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica S. Cuore, Roma, Italy

  Raimondo De Cristofaro

  26-10-2026

  https://doi.org/10.4081/btvb.2026.861

  0

  PDF: 0